The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses

代理终结点 医学 临床终点 梅德林 终点测定 临床试验 肿瘤科 随机对照试验 内科学 终点 医学物理学 几何学 政治学 数学 法学
作者
Vinay K. Prasad,Chul Kim,Mauricio Burotto,Andrae Vandross
出处
期刊:JAMA Internal Medicine [American Medical Association]
卷期号:175 (8): 1389-1389 被引量:460
标识
DOI:10.1001/jamainternmed.2015.2829
摘要

IMPORTANCE: The strength of association between surrogate end points and survival in oncology is important to understand because surrogate end points are frequently used in oncology clinical trials, supporting US Food and Drug Administration approvals and National Comprehensive Cancer Network guideline recommendations. OBJECTIVE: To identify and evaluate trial-level meta-analyses of randomized clinical trials quantifying the association between a surrogate end point and overall survival in medical oncology. Trial-level correlations test whether treatments that improve the surrogate end point also improve the final end point and are widely considered the strongest evidence to validate a surrogate end point. EVIDENCE REVIEW: Our literature search was built on earlier reported data sets and updated with Google Scholar and MEDLINE searches conducted on December 26, 2014. For MEDLINE, search terms included ("regression" or "correlation") and "surrogate" and "end point [or endpoint]" and ("oncology" or "cancer"). For Google scholar, search terms included ("regression" or "correlation") and "surrogate end point [or endpoint]" and "overall survival" and "trial level." A total of 108 abstracts were retrieved, and 62 articles were read in full in addition to articles identified through prior reviews. FINDINGS: We found 36 articles in which 65 specific correlations between a surrogate end point and survival were identified. Surrogate end points were studied in the neoadjuvant, adjuvant, locally advanced, and metastatic settings. The most common sources for trials included in the 36 articles were systematic reviews of the published literature (10 of 36; 28%), and published literature and meeting abstracts (14 of 36; 39%). Four meta-analyses (11%) used a convenience sample, and only 5 studies (14%) attempted to include unpublished trials by surveying clinical trial registries. Among these 5 studies, only 352 of 684 eligible trials (51.1%) were included in the analyses. More than half of reported correlations (34 of 65; 52%) were of low strength (r ≤ 0.7). Approximately a quarter (16 of 65; 25%) were of medium strength (r > 0.7 to r < 0.85), and 15 of 65 (23%) were highly correlated (r ≥ 0.85) with survival. CONCLUSIONS AND RELEVANCE: Most trial-level validation studies of surrogate end points in oncology find low correlations with survival. All validation studies use only a subset of available trials. The evidence supporting the use of surrogate end points in oncology is limited.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
别摆烂了完成签到,获得积分10
1秒前
陆lu完成签到,获得积分10
1秒前
2秒前
2秒前
大个的应助被神勇的曼文采纳,获得10
3秒前
3秒前
4秒前
打打的应助被司徒宝采纳,获得10
4秒前
uri发布了新的文献求助10
4秒前
369ninja的应助被青丝采纳,获得10
5秒前
所所的应助被wang采纳,获得10
5秒前
5秒前
李健的应助被AA采纳,获得10
5秒前
daomaihu发布了新的文献求助100
7秒前
哈哈哈完成签到,获得积分10
7秒前
吃猫的鱼发布了新的文献求助10
9秒前
9秒前
9秒前
荣离枯发布了新的文献求助10
9秒前
YU发布了新的文献求助10
9秒前
9秒前
惠1完成签到,获得积分10
10秒前
power发布了新的文献求助10
10秒前
传奇3的应助被wang采纳,获得10
10秒前
小薇薇完成签到,获得积分20
11秒前
11秒前
11秒前
王士豪发布了新的文献求助10
12秒前
www完成签到,获得积分10
12秒前
一路顺风完成签到 ,获得积分10
13秒前
高高靳发布了新的文献求助10
14秒前
gemma发布了新的文献求助30
14秒前
无心的谷槐完成签到,获得积分10
14秒前
万能图书馆的应助被大壮采纳,获得10
14秒前
领导范儿的应助被cccsh采纳,获得30
15秒前
乐乐的应助被CinBatt采纳,获得10
16秒前
16秒前
信仰发布了新的文献求助10
18秒前
19秒前
司徒宝发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175267
求助须知:如何正确求助?哪些是违规求助? 9567035
关于积分的说明 21789830
捐赠科研通 7769741
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556149
邀请新用户注册赠送积分活动 2477241